Mizuho Markets Cayman’s Pfizer PFE Stock Holding History

Mizuho Markets Cayman’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,150	Closed	-$259K	–	106
2021 Q1	$259K	Buy	+7,150	New	+$254K	0.03%	68
2020 Q2	–	Sell	-7,035	Closed	-$218K	–	77
2020 Q1	$218K	Buy	+7,035	New	+$240K	0.05%	51

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mizuho Markets Cayman's PFE Position: Q2 2021 in Review

Mizuho Markets Cayman sold out of Pfizer (PFE) in Q2 2021, closing a stake of 7,150 shares — an estimated $259K sold.

Mizuho Markets Cayman first reported a position in PFE in Q1 2020 and held it in 2 quarters. The position peaked at $259K in Q1 2021. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Mizuho Markets Cayman reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Mizuho Markets Cayman sold 7,150 Pfizer shares in Q2 2021, an estimated $259K.
Mizuho Markets Cayman first reported a position in Pfizer in Q1 2020 and held it in 2 quarters.
Mizuho Markets Cayman's Pfizer position peaked at $259K in Q1 2021.
2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Mizuho Markets Cayman's 13F filing for Q2 2021, filed 28 Jul 2021.